Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GW823093 Japan Phase IIa Mono

Trial Profile

GW823093 Japan Phase IIa Mono

Discontinued
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2018

At a glance

  • Drugs Denagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 20 Oct 2009 Planned end date (1 Oct 2007) added as reported by ClinicalTrials.gov.
    • 15 Oct 2008 Actual start date changed from Apr 2006 to May 2006 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top